Publications by authors named "Nicholas K Proctor"

Claim this Profile
M
MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.
Christopher Lloyd, Per-Ola Freskgård, Philip Newton, David Lowne, Adrian Nickson, Nicholas Kyle Proctor

Alzheimers Dement· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Olivia Wagemann, Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Nicholas K Proctor

JAMA Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
Michelle M Mielke, Jeremiah A Aakre, Alicia Algeciras-Schimnich, Nicholas K Proctor, Mary M Machulda

Alzheimers Dement· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
Elisabeth H Thijssen, Renaud La Joie, Amelia Strom, Corrina Fonseca, Leonardo Iaccarino, Nicholas K Proctor

Lancet Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
Adam M Brickman, Jennifer J Manly, Lawrence S Honig, Danurys Sanchez, Dolly Reyes-Dumeyer, Nicholas Kyle Proctor

Alzheimers Dement· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study.
James A Hendrix, David C Airey, Angela Britton, Anna D Burke, George T Capone, Nicholas Kyle Proctor

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
Shorena Janelidze, David Berron, Ruben Smith, Olof Strandberg, Nicholas K Proctor

JAMA Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.
Nicholas C Cullen, Antoine Leuzy, Sebastian Palmqvist, Shorena Janelidze, Erik Stomrud, Nicholas K Proctor

Nat Aging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Sebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, Henrik Zetterberg, Francisco Lopera, Nicholas K Proctor

JAMA· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.
Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, Nicholas K Proctor

Nat Commun· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Nicholas K Proctor

Nat Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Elisabeth H Thijssen, Renaud La Joie, Amy Wolf, Amelia Strom, Ping Wang, Nicholas K Proctor

Nat Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis